AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Find Visa cards with the highest cashback and no annual fee to maximize your savings on everyday spending. Discover your best options today.
28,655 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A high-profile Ethereum MEV exploit tied to the Jaredfromsubway bot has seen the attacker move millions via Tornado C...
U.S. equity markets tumbled as traders priced in a looming memory supply crisis in chipmakers, triggering a broad tec...
In a watershed move, Alphabet will join the Dow, while Verizon exits, as investors weigh AI investments against stead...
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...
A June selloff tested leverage in Bitcoin-backed corporate debt, but the market has steadied. Dividend payments persi...
SBI Holdings, Ripple’s biggest shareholder outside the United States, is quietly developing institutional XRP lending...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...
January data show a pending home sales fall, signaling continued headwinds for buyers even as rates move modestly low...
Urban Outfitters’ namesake stores are lifting results as fourth-quarter earnings beat expectations, signaling a broad...
VanEck BDC Income ETF faces pressure from rate cuts eating into floating-rate loan income. Distributions declined in ...
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...